HEOR Staff Writer

Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
Masitinib Prostate Cancer Trial Gains FDA and EMA Approval for Phase 3 Study
10-Year Health Plan: Transforming England’s NHS for the Future
Pharma Ad Spending Trends: Insights from the Top 10 Drug Advertisers of 2024
Pharmaceutical Industry Europe: Key Insights and Future Challenges for 2025
Transparency in Industry Partnerships: Building Trust